FORNARO, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 400
EU - Europa 183
AS - Asia 124
AF - Africa 72
Totale 779
Nazione #
US - Stati Uniti d'America 398
SG - Singapore 72
SE - Svezia 65
IT - Italia 54
CI - Costa d'Avorio 50
CN - Cina 29
GB - Regno Unito 25
SN - Senegal 17
DE - Germania 15
TR - Turchia 13
AT - Austria 11
HK - Hong Kong 6
NG - Nigeria 5
BG - Bulgaria 3
CA - Canada 2
FI - Finlandia 2
PL - Polonia 2
RO - Romania 2
AL - Albania 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ES - Italia 1
IN - India 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
Totale 779
Città #
Chandler 86
Abidjan 50
Santa Clara 33
Singapore 33
Boardman 28
New York 27
Florence 21
London 19
Dakar 17
Fairfield 15
Lawrence 15
Princeton 15
Istanbul 13
Ashburn 12
Medford 11
Vienna 11
Wilmington 10
Kent 8
Bremen 7
Ogden 7
San Diego 7
Shanghai 7
Hong Kong 6
Houston 6
Quanzhou 6
Fuzhou 5
Lagos 5
Pisa 5
Turin 5
Council Bluffs 4
Seacroft 4
Cascina 3
Frankfurt am Main 3
Los Angeles 3
Milan 3
Redmond 3
Sofia 3
Vicopisano 3
Woodbridge 3
Fort Worth 2
Lappeenranta 2
Munich 2
Warsaw 2
Boydton 1
Bucharest 1
Cambridge 1
Cento 1
Eagleville 1
Edmonton 1
Elk Grove Village 1
Guangzhou 1
Hyderabad 1
Islington 1
Kish 1
Leawood 1
Norwalk 1
Olomouc 1
Pietrasanta 1
Pistoia 1
Taizhou 1
Tallinn 1
Tirana 1
Toronto 1
Verona 1
Washington 1
Yokohama 1
Totale 553
Nome #
Cholangiocarcinoma: new perspectives for new horizons 59
Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab 51
The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer 49
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer 47
Combination chemotherapy in patients with advanced pancreatic cancer with an eastern cooperative oncology group performance status of 2: Lights and shadows of a frail route 45
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 44
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 43
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 43
Association of NOS3 and ANGPT2 gene polymorphisms with survival in patients with hepatocellular carcinoma receiving sorafenib: Results of the multicenter prospective INNOVATE study 42
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis 42
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: Clinics and pathology are not enough 37
FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer 36
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 35
Effects of Metformin and Vitamin D on Clinical Outcome in Cholangiocarcinoma Patients 34
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors 31
Second-line chemotherapy in advanced biliary cancer: The present now will later be past 26
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab 24
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 22
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action 16
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer 15
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population 11
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 10
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 10
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 9
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 9
Abdominal Visceral-to-Subcutaneous Fat Volume Ratio Predicts Survival and Response to First-Line Palliative Chemotherapy in Patients with Advanced Gastric Cancer 7
Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Carcinomatosis: The Need for Clear Answers Through Proper Questions 6
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution 5
Totale 808
Categoria #
all - tutte 5.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 0 0 44 0 4 2 19 15 28
2022/2023348 30 62 27 10 35 30 1 30 84 1 32 6
2023/2024150 9 14 22 4 20 20 15 0 6 3 17 20
2024/2025198 5 61 35 53 44 0 0 0 0 0 0 0
Totale 808